hC Bioscience
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Broadway, Cambridge, Massachusetts, 02...Phone Number
(617) 515-6755Website
www.hcbioscience.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About hC Bioscience
Based in Cambridge, MA, and founded in 2021, hC Bioscience is a biotechnology company with a focus on tRNA therapies.Explore more
hC Bioscience Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is hC Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if hC Bioscience had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at hC Bioscience
Earning: See what the market has to say on hC Bioscience recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when hC Bioscience launches new products
Funding: Get notified immidiatlly once hC Bioscience has new funding data
Check out if hC Bioscience is spiking on competitors!
hC Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Check if hC Bioscience has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at hC Bioscience
Find more new buyers
Compare Similar Companies to hC Bioscience
Compare insights from companies similar to hC Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
hC Bioscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
hC Bioscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about hC Bioscience.
hC Bioscience financials insights
Gather financial insights about hC Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Unspecified
$12M
2022
Series A
$24M
hC Bioscience Tech Stack
A closer look at the technologies used by hC Bioscience
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Layoffs
Layoffs
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Danielle Ladwig, Director, Process Development, has left the organization and now serves as Associate Director at CSL Ltd.
New Hire
Executive Move
hC Bioscience News & Media
hC Bioscience Announces Program in Duchenne Muscular Dystrophy and Reports In Vivo Data From tRNA-based Protein Editing Platform
BOSTON--(BUSINESS WIRE)--hC Bioscience announces program in Duchenne muscular dystrophy and reports in vivo data showing therapeutic potential of tRNA-based protein editing.hC Bioscience Presents Preclinical Data at ASGCT Showing Strong Potential in Hemophilia A Using tRNA-based Protein Editing Platform
BOSTON--(BUSINESS WIRE)--hC Bioscience, a biopharmaceutical company developing a fundamentally novel approach to treating genetic diseases through tRNA-based protein editing, today presented preclinical data supporting its lead program in severe hemophilia A at the American Society of Gene and Cell Therapy Annual Meeting in Baltimore, Md. Suchul Jang, Ph.D., Senior Director, Biology, presented data demonstrating that HCB-101, an anticodon engineered (ACE) tRNA, restores production of full-lengthC Bioscience Announces Lead Program in Hemophilia and Reports Positive Preclinical Data on Novel Protein Editing Approach Using Anticodon Engineered tRNA
BOSTON--(BUSINESS WIRE)--hC Bioscience announces lead program in severe hemophilia A and shares preclinical data demonstrating proof-of-concept for tRNA-based protein editing.hC Bioscience Appoints Jose Lora, Ph.D., as Chief Scientific Officer to Lead Development of the Company's Therapeutic tRNA
Boston, Massachusetts--(Newsfile Corp. - September 25, 2023) - hC Bioscience has appointed Jose Lora, Ph.D., as its Chief Scientific Officer (CSO). In this position, Lora will play a pivotal role in helping to shape the Company's strategic direction around its innovative portfolio of therapeutic tRNAs and advancing their lead candidates into the clinic. To view the full announcement, including downloadable images, bios, and more, click here. Key...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding hC Bioscience
Sign Up For FreeTo access detailed company insights
Based in Cambridge, MA, and founded in 2021, hC Bioscience is a biotechnology company with a focus on tRNA therapies.... Read More
